Klara-Luisa Budau - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Klara-Luisa Budau

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Deutsche Medizinische Wochenschrift (1946)|February 9, 2026

[Acute-on-chronic liver failure]Klara-Luisa Budau, Robert Thimme, Lukas Sturm

Journal of Cancer|June 17, 2022

Prognostic Impact of Tumor Budding in Intrahepatic Cholangiocellular CarcinomaKlara-Luisa Budau, Carlie S Sigel, Luise Bergmann, et al.

Nature Communications|March 24, 2026

Proteomic characterization of intrahepatic cholangiocarcinoma identifies risk-stratifying subgroups and EIF4A1 as a therapeutic targetTilman Werner, Johanna Thiery, Klara-Luisa Budau, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Deutsche Medizinische Wochenschrift (1946)|February 9, 2026

[Acute-on-chronic liver failure]Klara-Luisa Budau, Robert Thimme, Lukas Sturm

Journal of Cancer|June 17, 2022

Prognostic Impact of Tumor Budding in Intrahepatic Cholangiocellular CarcinomaKlara-Luisa Budau, Carlie S Sigel, Luise Bergmann, et al.

Nature Communications|March 24, 2026

Proteomic characterization of intrahepatic cholangiocarcinoma identifies risk-stratifying subgroups and EIF4A1 as a therapeutic targetTilman Werner, Johanna Thiery, Klara-Luisa Budau, et al.

Pageof 1